[HTML][HTML] Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

D Planchard, ST Popat, K Kerr, S Novello, EF Smit… - Annals of …, 2018 - Elsevier
Primary lung cancer remains the most common malignancy after non-melanocytic skin
cancer, and deaths from lung cancer exceed those from any other malignancy worldwide [1] …

Leukaemia: a model metastatic disease

AE Whiteley, TT Price, G Cantelli, DA Sipkins - Nature Reviews Cancer, 2021 - nature.com
In contrast to solid cancers, which often require genetic modifications and complex cellular
reprogramming for effective metastatic dissemination, leukaemic cells uniquely possess the …

Non-oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up☆

LE Hendriks, KM Kerr, J Menis, TS Mok… - Annals of …, 2023 - annalsofoncology.org
Diagnosis of tumour type allows prognostication and triage for biomarker testing (see the
Supplementary Material Section 3 and Supplementary Figure S1, available at https://doi …

[HTML][HTML] Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

PE Postmus, KM Kerr, M Oudkerk, S Senan… - Annals of oncology, 2017 - Elsevier
Lung cancer is the leading cause of cancer mortality worldwide with 1.8 million newly
diagnosed cases, or 13% of all cancers diagnosed, in 2012 [1]. The worldwide numbers are …

The eighth edition lung cancer stage classification

FC Detterbeck, DJ Boffa, AW Kim, LT Tanoue - Chest, 2017 - Elsevier
Stage classification provides a nomenclature about the anatomic extent of a cancer; a
consistent language provides the ability to communicate about a specific patient and about …

[HTML][HTML] Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

S Novello, F Barlesi, R Califano, T Cufer, S Ekman… - Annals of …, 2016 - Elsevier
In 2012, lung cancer was the most frequently diagnosed cancer and the leading cause of
cancer death in male populations. Among females, lung cancer was the leading cause of …

[HTML][HTML] Correction to:“Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up”

D Planchard, S Popat, K Kerr, S Novello, EF Smit… - Annals of …, 2019 - Elsevier
1. In KEYNOTE-189, patients with metastatic non-squamous NSCLC, PS 0-1, without
sensitising EGFR or ALK mutations, were randomised to receive pemetrexed and a platinum …

[HTML][HTML] Pan-Asian adapted Clinical Practice Guidelines for the management of patients with metastatic non-small-cell lung cancer: a CSCO–ESMO initiative endorsed …

YL Wu, D Planchard, S Lu, H Sun, N Yamamoto… - Annals of …, 2019 - Elsevier
The most recent version of the European Society for Medical Oncology (ESMO) Clinical
Practice Guidelines for the diagnosis, treatment and follow-up of metastatic non-small-cell …

Lung cancer—major changes in the American Joint Committee on Cancer eighth edition cancer staging manual

R Rami‐Porta, H Asamura, WD Travis… - CA: a cancer journal …, 2017 - Wiley Online Library
Answer questions and earn CME/CNE The revision for the eighth edition of the tumor, node,
and metastasis (TNM) classification of lung cancer was based on analyses of the …

Quantifying cell divisions along evolutionary lineages in cancer

M Blohmer, DM Cheek, WT Hung, M Kessler… - Nature Genetics, 2025 - nature.com
Cell division drives somatic evolution but is challenging to quantify. We developed a
framework to count cell divisions with DNA replication-related mutations in polyguanine …